相关实验视频
Updated: Sep 10, 2025
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
22.0K
循环中的阿波利波蛋白:在血栓形成和中风开始的界面上
Tamara Etuze1, Denis Vivien2, Fatemeh Dubois3
1Normandie University, UNICAEN, INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Institut Blood and Brain @ Caen-Normandie (BB@C), 14000 Caen, France.
Progress in lipid research
|August 20, 2025
概括
脂质代谢中的关键蛋白质阿波利波蛋白在缺血性中风的发展中起着至关重要的作用. 了解它们的不平衡为中风预防和治疗提供了新的途径.
科学领域:
- 心血管生物学 心血管生物学
- 神经科学是一个神经科学.
- 脂质代谢 脂质代谢是什么
背景情况:
- 缺血性中风是一个主要的全球健康问题,通常是由动脉样硬化和血栓引起的.
- 目前的急性治疗改善了结果,但识别上游分子原因对于预防和风险评估至关重要.
研究的目的:
- 审查阿波利波蛋白在系统血管生物学中的作用及其对中风发病的贡献.
- 探索阿波利波蛋白如何影响动脉动脉生成,斑块稳定性,凝血和免疫反应.
- 突出阿波利波蛋白作为潜在的生物标记物和缺血性中风的治疗点.
主要方法:
- 关于血管生物学和中风中阿波利波蛋白的最新证据的文献综述.
- 分析阿波利波蛋白对动脉动脉产生,斑块不稳定性,凝血和免疫内皮相互作用的影响.
- 检查阿波利波蛋白失衡作为中风风险预测因素.
主要成果:
- 脂蛋白是关键的媒介,将脂质代谢,炎症,内皮功能障碍和血栓形成联系起来.
- 特定的阿波利波蛋白影响动脉生成,斑块脆弱性,凝血和血小板功能.
- 脂蛋白失衡可能比传统的脂质水平更好地预测中风风险.
结论:
- 脂蛋白是缺血性中风病原体的核心,影响多种血管过程.
- 功能性阿波利波蛋白失衡为失脂症,免疫激活和血栓炎症提供了新的见解.
- 脂蛋白代表了新的中风预防和治疗策略的有希望的目标.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
01:16Clot Retraction and Fibrinolysis
6.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.8K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
645
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
645
01:22Formation of the Platelet Plug
7.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.1K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K